Enabling the shift from treatment to prevention in healthcare
Stay up-to-date with LAMPseq on:

Prevention in a new dimension - LAMPseq enables solutions for uncomplicated and personal Health Management

LAMPseq is the innovative technology with PCR accuracy and at a fraction of the known cost. Developed during the COVID-19 pandemic and applicable to a wide range of pathogens, it opens up a new dimension in diagnostic testing. Tomorrow’s health is today’s prevention. Testing large numbers of samples at low cost opens the way to affordable testing services for personal preventive health care. Prevention means safety from severe disease progression and cost reduction in the healthcare system.

LAMPseq Testing

LAMPseq solutions offer borderless diagnostics.

  • For the strategic prevention and operational control of infectious diseases
  • For new dimensions in price, throughput, laboratory process costs, and profit margins.
  • Certification according to IVDD and IVDR
LAMPseq Products

Ready to give it a try?
Let LAMPseq provide you with quick, efficient and cost-effective support!

Contact us

The Technology Behind LAMPseq

Ein Wissenschaftler steht im Labor des Biotech Unternehmens LAMPseq Diagnostics in Bonn und bedient ein Sequenziergerät von Illumina

Advances in technology are great, but can be difficult to understand. That’s why we’ve set out to explain the technology of LAMPseq in simple terms. 

At a Glance
Pipetten eines Diagnostikgeräts gefüllt mit Probematerial eines Nukleinsäuretests zur Coronatestung

For an in-depth explanation of the technology behind LAMPseq, we have provided a more comprehensive description of the process. This explanation is supported by a paper published in ‘Nature Biotechnology’ which offers detailed information to those of a more technical acumen.

For Experts
Ein Laptop welcher die LAMPseq Diagnostics peer-review Studie in Nature Biotechnology zeigt

In 2021, the renowned journal, 'Nature Biotechnology' published study results on the LAMPseq method.

After an independent peer review process scientific study results on the LAMPseq method were published in the renowned journal ‘Nature Biotechnology’. Lead authors of the study are the two founders and shareholders of LAMPseq, Dr. Kerstin Ludwig and Prof. Dr. Jonathan Schmid-Burgk.

See the Study

LAMPseq in the News

Das Logo des westdeutschen Rundfunks zur Berichterstattung über LAMPseq Diagnosics und die Uniklinik Bonn
Das Logo der Zeitschrift 'Management&Krankenhaus' zur Berichterstattung über LAMPseq Diagnosics und die Uniklinik Bonn
Das Logo der Zeitschrift 'The Science Times' zur Berichterstattung über LAMPseq Diagnosics und die Uniklinik Bonn
Das Logo der Lokalzeitschrift 'General Anzeiger Bonn' zur Berichterstattung über LAMPseq Diagnosics und die Uniklinik Bonn
Das Logo des SWR zur Berichterstattung über LAMPseq Diagnosics und die Uniklinik Bonn
More of LAMPseq in den News​

LAMPseq Leadership

Ein Portrait von Claudia Krcmar, CEO der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Claudia Krcmar

Diploma in Business Administration, CEO

Ein Portrait von Prof. Dr. Kerstin Ludwig, CMO, Co-Founderin und Humangenetikerin der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Dr. Kerstin
Ludwig

Professor of Human Genetics
Co-Founder & CMO

Ein Portrait von Professor Jonathan Schmid-Burgk, CDO, Co-Funder und Humangenetiker der LAMPseq Diagnostics GmbH, einem Biotech Unternehmen aus Bonn

Dr. Jonathan
Schmid-Burgk

Professor of Immunology
Co-Founder & CDO

Learn more about us

Looking to get in touch with LAMPseq?

Contact
Das LAMPseq Diagnostics GmbH Logo in weiß und orange

Enabling the transition from treatment to prevention in healthcare

Contact

Address

Venusberg-Campus 1
Gebäude 76
53127 Bonn

Work with LAMPseq

News

© 2022 – Designed with  by Minerva Kreativagentur

Imprint | Privacy Policy
Die LAMPseq Diagnostics GmbH Bildmarke ist ein orangenes Q, welches aussieht wie eine Lupe

We innovate diagnostics to inform next-level medical decisions.

We are currently in the process of redesigning our website.

In the meantime, you can view some of our work and see what were up to on LinkedIn.

Do you already have a project you want to talk to us about? Get in touch